28086917|t|Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.
28086917|a|BACKGROUND: Treatment of mild-moderate Alzheimer's disease (AD) subjects (N = 119) for 52 weeks with the SIRT1 activator resveratrol (up to 1 g by mouth twice daily) attenuates progressive declines in CSF Abeta40 levels and activities of daily living (ADL) scores. METHODS: For this retrospective study, we examined banked CSF and plasma samples from a subset of AD subjects with CSF Abeta42 <600 ng/ml (biomarker-confirmed AD) at baseline (N = 19 resveratrol-treated and N = 19 placebo-treated). We utilized multiplex Xmap technology to measure markers of neurodegenerative disease and metalloproteinases (MMPs) in parallel in CSF and plasma samples. RESULTS: Compared to the placebo-treated group, at 52 weeks, resveratrol markedly reduced CSF MMP9 and increased macrophage-derived chemokine (MDC), interleukin (IL)-4, and fibroblast growth factor (FGF)-2. Compared to baseline, resveratrol increased plasma MMP10 and decreased IL-12P40, IL12P70, and RANTES. In this subset analysis, resveratrol treatment attenuated declines in mini-mental status examination (MMSE) scores, change in ADL (ADCS-ADL) scores, and CSF Abeta42 levels during the 52-week trial, but did not alter tau levels. CONCLUSIONS: Collectively, these data suggest that resveratrol decreases CSF MMP9, modulates neuro-inflammation, and induces adaptive immunity. SIRT1 activation may be a viable target for treatment or prevention of neurodegenerative disorders. TRIAL REGISTRATION: ClinicalTrials.gov NCT01504854.
28086917	0	11	Resveratrol	Chemical	MESH:D000077185
28086917	22	40	neuro-inflammation	Disease	MESH:D007249
28086917	74	93	Alzheimer's disease	Disease	MESH:D000544
28086917	134	153	Alzheimer's disease	Disease	MESH:D000544
28086917	155	157	AD	Disease	MESH:D000544
28086917	200	205	SIRT1	Gene	23411
28086917	216	227	resveratrol	Chemical	MESH:D000077185
28086917	458	460	AD	Disease	MESH:D000544
28086917	479	486	Abeta42	Gene	351
28086917	519	521	AD	Disease	MESH:D000544
28086917	543	554	resveratrol	Chemical	MESH:D000077185
28086917	652	677	neurodegenerative disease	Disease	MESH:D019636
28086917	808	819	resveratrol	Chemical	MESH:D000077185
28086917	841	845	MMP9	Gene	4318
28086917	890	893	MDC	Gene	6367
28086917	896	914	interleukin (IL)-4	Gene	3565
28086917	920	952	fibroblast growth factor (FGF)-2	Gene	2247
28086917	976	987	resveratrol	Chemical	MESH:D000077185
28086917	1005	1010	MMP10	Gene	4319
28086917	1048	1054	RANTES	Gene	6352
28086917	1081	1092	resveratrol	Chemical	MESH:D000077185
28086917	1213	1220	Abeta42	Gene	351
28086917	1272	1275	tau	Gene	4137
28086917	1335	1346	resveratrol	Chemical	MESH:D000077185
28086917	1361	1365	MMP9	Gene	4318
28086917	1377	1395	neuro-inflammation	Disease	MESH:D007249
28086917	1428	1433	SIRT1	Gene	23411
28086917	1499	1526	neurodegenerative disorders	Disease	MESH:D019636
28086917	Positive_Correlation	MESH:D000077185	6367
28086917	Positive_Correlation	MESH:D000077185	23411
28086917	Positive_Correlation	MESH:D000077185	2247
28086917	Association	MESH:D000077185	MESH:D007249
28086917	Negative_Correlation	MESH:D000077185	MESH:D000544
28086917	Positive_Correlation	MESH:D000077185	4319
28086917	Association	MESH:D019636	23411
28086917	Negative_Correlation	MESH:D000077185	4318
28086917	Negative_Correlation	MESH:D000077185	351
28086917	Negative_Correlation	MESH:D000077185	6352
28086917	Association	MESH:D000544	351
28086917	Positive_Correlation	MESH:D000077185	3565

